1. Home
  2. LYRA vs MSN Comparison

LYRA vs MSN Comparison

Compare LYRA & MSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LYRA
  • MSN
  • Stock Information
  • Founded
  • LYRA 2005
  • MSN 1948
  • Country
  • LYRA United States
  • MSN United States
  • Employees
  • LYRA N/A
  • MSN N/A
  • Industry
  • LYRA Medical/Dental Instruments
  • MSN Consumer Electronics/Appliances
  • Sector
  • LYRA Health Care
  • MSN Consumer Staples
  • Exchange
  • LYRA Nasdaq
  • MSN Nasdaq
  • Market Cap
  • LYRA 11.3M
  • MSN 9.5M
  • IPO Year
  • LYRA 2020
  • MSN 1994
  • Fundamental
  • Price
  • LYRA $6.37
  • MSN $0.52
  • Analyst Decision
  • LYRA Hold
  • MSN
  • Analyst Count
  • LYRA 1
  • MSN 0
  • Target Price
  • LYRA $16.00
  • MSN N/A
  • AVG Volume (30 Days)
  • LYRA 49.1K
  • MSN 2.9M
  • Earning Date
  • LYRA 11-11-2025
  • MSN 11-13-2025
  • Dividend Yield
  • LYRA N/A
  • MSN N/A
  • EPS Growth
  • LYRA N/A
  • MSN N/A
  • EPS
  • LYRA N/A
  • MSN N/A
  • Revenue
  • LYRA $770,000.00
  • MSN $10,262,000.00
  • Revenue This Year
  • LYRA N/A
  • MSN N/A
  • Revenue Next Year
  • LYRA $106.28
  • MSN N/A
  • P/E Ratio
  • LYRA N/A
  • MSN N/A
  • Revenue Growth
  • LYRA N/A
  • MSN 8.49
  • 52 Week Low
  • LYRA $3.81
  • MSN $0.28
  • 52 Week High
  • LYRA $37.50
  • MSN $0.85
  • Technical
  • Relative Strength Index (RSI)
  • LYRA 39.68
  • MSN 50.91
  • Support Level
  • LYRA $6.25
  • MSN $0.47
  • Resistance Level
  • LYRA $7.30
  • MSN $0.77
  • Average True Range (ATR)
  • LYRA 0.60
  • MSN 0.12
  • MACD
  • LYRA -0.13
  • MSN -0.00
  • Stochastic Oscillator
  • LYRA 8.98
  • MSN 18.80

About LYRA Lyra Therapeutics Inc.

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

About MSN Emerson Radio Corporation

Emerson Radio Corp operates in the consumer electronics industry. The company designs, sources, imports, and markets a variety of houseware and consumer electronic products, and licenses the Emerson trademark domestically and internationally. The products offered by the company are televisions, digital versatile disc players and video cassette recorders, audio accessories, microwave ovens, home theatres, high-end audio products, office products, mobile stereo, and wireless products.

Share on Social Networks: